Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 2,084 shares at $549.00 ($1.1M) on 2021-06-25, disclosed to the SEC on 2021-06-28.
Open-market sale of $1.1M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |